floblu14,
...I sold out today...was sincerely hoping Ampha would be reversed making my 3 year $65 SP prognostication feasable.
For me instead today's judgement was strike three.
...As to your Bullish scenarios.
1/
Why didn't NVS takeout MNTA after M enox FDA approval?
Now we know why.
2/
Baxter got many MNTA compounds for didley squat $$$ up front....and confirmed yesterday...two more for free.
(another reason Bax won't be buying out MNTA)
402 will require years of trials.
3/
Today's judgement sets MNTA back until at least Jan/13 and I can only see mnta settling at horrible terms...so they may as well go to trial... they will wait to see if they are allowed to.
All in all, imo,
...MNTA mgmnt knew all along they were longshot winners in today's outcome
...and who knows what the copax scenarios will be like in 2014/2015
hence their deal with Baxter.
y3
Market Data 
Markets 
AI
